Home›Companies›Healthcare›Wesper

Wesper Inc.

Home sleep testing devices and services for healthcare providers and their patients.

Updated Nov 10, 2026·Latest SEC filing Jul 14, 2026·Suggest an edit

About Wesper

Wesper is a private company based in New York, New York. It has reported $23,526,492 raised in three offerings on Form D since February 2020. Its chief executive is Amir Reuveny.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 5, 2024Jul 14, 2026$8,304,999fully sold12$692KEquity, Debt, Options, Securities on exerciseRule 506(b)Form D ↗
May 12, 2022Jul 14, 2026$9,584,500fully sold20$479KEquity, Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Feb 11, 2020Feb 26, 2020$5,636,993of $5.6M target14$402KEquityRule 506(b)Form D ↗
Total, three offerings$23,526,492

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Wesper's Form D filed Jul 14, 2026.

Amir Reuveny
Amir Reuveny
Co-Founder & CEO

Earlier filings also listed Santo Politi (director, last listed Feb 2020).

Sources

  1. SECWesper Inc. filing history
  2. CompanyAbout Wesper
  3. CompanyContact Wesper
  4. ResearchEvaluation of an automated sleep apnea scoring algorithm